Matrix metalloproteinases and tumor metastasis
The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–220 of 220
TaqMan ® -Based Quantification of Invasive Cells in the Chick Embryo Metastasis assay
van der Horst, E. H., Leupold, J. H., Schubbert, R., et al. (2004) · BioTechniques · doi:10.2144/04376st02 · Cited by 54
Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells
Soulié, P., Carrozzino, F., Pepper, M. S., Strongin, A. Y., Poupon, M., & Montesano, R. (2004) · Oncogene · doi:10.1038/sj.onc.1208360 · Cited by 54
Pericyte-Like Location of GFP-Tagged Melanoma Cells
Lugassy, C., Kleinman, H. K., Engbring, J. A., Welch, D. R., Harms, J. F., Rufner, R., Ghanem, G., Patierno, S. R., & Barnhill, R. L. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63207-5 · Cited by 52
Different Roles for Plasminogen Activators and Metalloproteinases in Melanoma Metastasis
Mueller, B. M. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-61107-0_5 · Cited by 50
Corneal Neovascularization after Excimer Keratectomy Wounds in Matrilysin-Deficient Mice
Kure, T., Chang, J.-H., Kato, T., Hernández-Quíntela, E., Ye, H., Lu, P. C.-S., Matrisian, L. M., Gatinel, D., Shapiro, S. D., Ghosheh, F. R., et al. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.01-1058 · Cited by 48
Wang, X.-Q., Sun, P., & Paller, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302211200 · Cited by 47
Yonemura, Y., Endo, Y., Fujita, H., Kimura, K., Sugiyama, K., Momiyama, N., Shimada, H., & Sasaki, T. (2001) · PubMed · Cited by 44
Mira, E., Lacalle, R. A., Gómez‐Moutón, C., Leonardo, E., & Mañes, S. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015563031769 · Cited by 44
Takahashi, M., Fukami, S., Iwata, N., Inoue, K., Itohara, S., Itoh, H., Haraoka, J., & Saido, T. C. (2002) · Pharmacological Research · doi:10.1016/s1043-6618(02)00081-6 · Cited by 43
Human and Rat Glioma Growth, Invasion, and Vascularization in a Novel Chick Embryo Brain Tumor Model
Cretu, A., Fotos, J. S., Little, B. W., & Galileo, D. S. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-7889-x · Cited by 42
Della Porta, P., Soeltl, R., Krell, H., Collins, K., O'Donoghue, M., Schmitt, M., & Krüger, A. (1999) · PubMed · Cited by 42
Dasgupta, S., Bhattacharya‐Chatterjee, M., O'Malley, B. W., & Chatterjee, S. K. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20647 · Cited by 41
Kong, Y., Poon, R. W. M., Nadesan, P., Muccio, T. D., Fodde, R., Khokha, R., & Alman, B. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3112 · Cited by 36
Kido, A., Tsutsumi, M., Iki, K., Takahama, M., Tsujiuchi, T., Morishita, T., Tamai, S., & Konishi, Y. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00368-1 · Cited by 36
Yui, S., Tomita, K., Kudo, T., Ando, S., & Yamazaki, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00097.x · Cited by 34
Chen, X., Su, Y. R., Fingleton, B., Acuff, H. B., Matrisian, L. M., Zent, R., & Pozzi, A. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-7453-8 · Cited by 32
Molina, J. R., Reid, J. M., Erlichman, C., Sloan, J. A., Furth, A. F., Safgren, S. L., Lathia, C. D., & Alberts, S. R. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000176504.86551.5c · Cited by 32
T Cell-Derived Matrix Metalloproteinase-9 in Breast Cancer: Friend or Foe?
Owen, J. L., Iragavarapu‐Charyulu, V., & Lopez, D. M. (2004) · Breast Disease · doi:10.3233/bd-2004-20115 · Cited by 28
藤野, 晴., Kondo, K., Ishikura, H., Maki, H., Kinoshita, H., Miyoshi, T., Takahashi, Y., Sawada, N., Takizawa, H., Nagao, T., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0031 · Cited by 21
Chu, J. H., Sun, Z. Y., Meng, X. L., Wu, J. H., He, G. L., Liu, G. M., & Jiang, X. R. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.03.034 · Cited by 20
Cited by
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
“The most important physiological inhibitors of MMP function are the tissue inhibitors of metalloproteinases (TIMPs), which are also commonly expressed in tumor sites (Deryugina and Quigley, 2006).”
BackgroundTherapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Contribution of platelets to tumour metastasis
Gay, L. J., & Felding-Habermann, B. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3004 · Cited by 1,645
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Metadata
- Authors
- Deryugina, E. I., & Quigley, J. P.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2006-03
- Volume
- 25
- Issue
- 1
- Pages
- 9-34
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1992885568
- Cited by
- 1,960
- References
- 220
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.